Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Feature Stories

Latest Feature Stories

A kala azar patient at Leer Hospital, Unity State, South Sudan, 2010. Photograph by Olga Overbeek
Feature story
Feature story |
04 June 2012
Research and development Tropical & neglected diseases Tuberculosis Vaccines

Health R&D convention talks still moving despite developed countries delay tactics

6 min
Aquil Bol Mallien, mother of twins at an MSF clinic in South Sudan. Photograph by MSF
Feature story
Feature story |
15 May 2012
Intellectual property and trade Vaccines

South Sudan: A mother's struggle to vaccinate her baby

Feature story |
15 May 2012
Intellectual property and trade Research and development Vaccines
Chad

Interview on strengthening the Expanded Programme on Immunisation: Lessons from Chad

4 min
Marking a vaccinated child's finger with gentian violet during a measles vaccination campaign (vaccinated nearly 14,500 children) in Doro refugee camp. Photograph by Robin Meldrum
Feature story
Feature story |
15 May 2012
Intellectual property and trade Research and development Vaccines
ChadNiger

View from the field: Why we need to simplify vaccination

4 min
Mother and children register for their Hepatitis-B Vaccination at the MSF Chapikarong clinic. February, 2009, Manipur, India. Photograph by Sami Siva
Feature story
Feature story |
19 April 2012
HIV/AIDS
IndiaMyanmar

MSF opens new HIV/AIDS clinic on India Myanmar border

Feature story |
10 April 2012
Malnutrition
Chad

Chad: villages organise themselves against malnutrition

Feature story |
10 April 2012
Intellectual property and trade
India

Background Information on India's First Compulsory Licence

6 min
Feature story |
10 April 2012
Malnutrition
Chad

Interview on MSF's study on how best to distribute supplementary food to prevent malnutrition

  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury